Lutris Pharma is a clinical stage biopharmaceutical company established with a vision to improve anti cancer therapy effectiveness as well as the quality of life for patients who are being treated with EGFR (Epidermal Growth Factor Receptor) Inhibitors or with Radiation.

Content Locked
Login or Register a FREE account to continue browsing our content
2015
Tel Aviv, Israel

11 - 50
Grant| Funding Round | Announced Date | Disclosed Investors | Round Amount (USD) |
|---|
Content Locked
Login or Register a FREE account to continue browsing our content